| abstract |
The present invention is a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D- to the use of peptide compounds of trp-Leu-Leu-NH 2 . Furthermore, the present invention relates to Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp- Phe-D-Trp-Leu-Leu-NH 2 peptide and optionally at least one pharmaceutically acceptable carrier, at least one cryoprotectant, at least one dispersion protectant, at least one excipient It relates to a pharmaceutical composition comprising an agent and / or at least one diluent, preferably in the form of a lyophilizate, a buffer, an artificial breast milk formulation or a breast milk substitute. |